[Federal Register Volume 62, Number 64 (Thursday, April 3, 1997)]
[Presidential Documents]
[Pages 16039-16051]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-8838]
[[Page 16037]]
_______________________________________________________________________
Part VII
The President
_______________________________________________________________________
Proclamation 6982--To Implement an Agreement To Eliminate Tariffs on
Certain Pharmaceuticals and Chemical Intermediates
Presidential Documents
Federal Register / Vol. 62, No. 64 / Thursday, April 3, 1997 /
Presidential Documents
___________________________________________________________________
Title 3--
The President
[[Page 16039]]
Proclamation 6982 of April 1, 1997
To Implement an Agreement To Eliminate Tariffs on
Certain Pharmaceuticals and Chemical Intermediates
By the President of the United States of America
A Proclamation
1. On December 13, 1996, members of the World Trade
Organization (WTO), including the United States and 16
other major trading countries, announced in the WTO
Singapore Ministerial Declaration an agreement to
eliminate tariffs on certain pharmaceuticals and
chemical intermediates that were the subject of
reciprocal duty elimination negotiations during the
Uruguay Round of multilateral trade negotiations
(``Uruguay Round''). In addition, it was agreed that
the agreement on pharmaceutical products reached at the
conclusion of the Uruguay Round and consequently
Schedule XX--United States of America, annexed to the
Marrakesh Protocol to the General Agreement on Tariffs
and Trade (1994) (``Schedule XX'') erroneously included
25 products.
2. (a) Section 111(b) of the Uruguay Round Agreements
Act (URAA) (19 U.S.C. 3521(b)) authorizes the President
to proclaim the modification of any duty or staged rate
reduction of any duty set forth in Schedule XX for
products that were the subject of reciprocal duty
elimination negotiations during the Uruguay Round if
the United States agrees to such action in a
multilateral negotiation under the auspices of the WTO
and after compliance with the consultation and layover
requirements of section 115 of the URAA (19 U.S.C.
3524). Section 111(b) also authorizes the President to
proclaim such modifications as are necessary to correct
technical errors in Schedule XX or to make other
rectifications to the Schedule.
(b) Section 111(a) of the URAA (19 U.S.C. 3521(a))
authorizes the President to proclaim such additional
duties as the President determines to be necessary or
appropriate to carry out Schedule XX.
3. Section 604 of the Trade Act of 1974 (1974 Act), as
amended (19 U.S.C. 2483), authorizes the President to
embody in the Harmonized Tariff Schedule of the United
States (HTS) the substance of the relevant provisions
of that Act, and of other acts affecting import
treatment, and actions thereunder, including the
removal, modification, continuance, or imposition of
any rate of duty or other import restriction.
4. (a) Pursuant to section 111(b) of the URAA, I have
determined that modifications to Schedule XX are
necessary and that Schedule XX should be modified
accordingly. In addition, I have determined to modify
the HTS to implement the multilateral agreement on
pharmaceuticals negotiated under the auspices of the
WTO.
(b) Pursuant to section 111(a) of the URAA, I have
determined that it is necessary or appropriate to
modify the HTS to increase tariffs on products that
were included erroneously in the pharmaceuticals
agreement reached at the end of the Uruguay Round.
(c) On January 29, 1997, pursuant to section 115 of
the URAA, the United States Trade Representative (USTR)
submitted a report to the Committee on Ways and Means
of the House of Representatives and the Committee on
Finance of the Senate (``the Committees'') that set
forth the proposed tariff eliminations and corrections
in existing tariff treatment, together with
[[Page 16040]]
the advice received from the appropriate private sector
advisory committee and the U.S. International Trade
Commission regarding such actions. During the 60-day
period thereafter, the USTR consulted with the
Committees on the proposed tariff eliminations and
corrections.
NOW, THEREFORE, I, WILLIAM J. CLINTON, President of the
United States of America, acting under the authority
vested in me by the Constitution and the laws of the
United States, including but not limited to sections
111(a) and (b) of the URAA and section 604 of the 1974
Act, do hereby proclaim that:
(1) In order to implement the multilateral
agreement negotiated under the auspices of the WTO to
eliminate tariffs on certain pharmaceutical products
and chemical intermediates, and to correct errors,
Schedule XX and the pharmaceutical appendix to the HTS
are modified as set forth in the Annex to this
proclamation.
(2) The modifications to the HTS set forth in this
proclamation shall be effective as provided in the
Annex to this proclamation.
(3) Any provisions of previous proclamations and
Executive orders that are inconsistent with the actions
taken in this proclamation are superseded to the extent
of such inconsistency.
IN WITNESS WHEREOF, I have hereunto set my hand this
first day of April, in the year of our Lord nineteen
hundred and ninety-seven, and of the Independence of
the United States of America the two hundred and
twenty-first.
(Presidential Sig.)
Billing code 3195-01-P
[[Page 16041]]
[GRAPHIC] [TIFF OMITTED] TD03AP97.002
[[Page 16042]]
[GRAPHIC] [TIFF OMITTED] TD03AP97.003
[[Page 16043]]
[GRAPHIC] [TIFF OMITTED] TD03AP97.004
[[Page 16044]]
[GRAPHIC] [TIFF OMITTED] TD03AP97.005
[[Page 16045]]
[GRAPHIC] [TIFF OMITTED] TD03AP97.006
[[Page 16046]]
[GRAPHIC] [TIFF OMITTED] TD03AP97.007
[[Page 16047]]
[GRAPHIC] [TIFF OMITTED] TD03AP97.008
[[Page 16048]]
[GRAPHIC] [TIFF OMITTED] TD03AP97.009
[[Page 16049]]
[GRAPHIC] [TIFF OMITTED] TD03AP97.010
[[Page 16050]]
[GRAPHIC] [TIFF OMITTED] TD03AP97.011
[[Page 16051]]
[GRAPHIC] [TIFF OMITTED] TD03AP97.012
[FR Doc. 97-8838 Filed 4-2-97; 1:54 pm]
BILLING CODE 3190-01-C
